Health Capital Helsinki
  • Home
  • Why Helsinki Metropolitan
  • About
  • News
  • Events
  • Opportunities
  • Careers
  • Contact
  • Search
  • Menu Menu
Jun 11, 2020

Mobile health amidst the Covid-19 crisis

Finnish health tech startup Etsimo Healthcare powers Brazil with its diagnosis engine.

Well, it is our partner techtools ventures calling. What do they have in mind this time?, wondered Thomas Grandell, CEO of Etsimo Healthcare, in April 2020.

Soon he would learn that the startup would expand its business to Brazil at a fast pace, amidst the Covid-19 pandemic.

There was a great need for Etsimo’s and techtools ventures’ mobile health and telehealth services in Minas Gerais, a state with over 20 million inhabitants in Brazil. At the core is a mobile application, which is powered with Etsimo’s technology platform, the diagnosis engine. 

Never say never as anything can happen. Telehealth used to be prohibited in Brazil, but Covid-19 changed this overnight.

Based on the patient’s symptoms, pre-existing conditions and basic information, the app makes a diagnosis and estimates the need for treatment. If there is a need, the patient gets a list of doctors to choose from and a virtual consultation with a doctor will follow.

“Never say never as anything can happen. Our relationship with techtools ventures was established during an export trip organized by Business Finland to Brazil in 2018. At that time telehealth was prohibited in the country, but Covid-19 changed this overnight,” says Grandell.

The need for healthcare is bigger than ever as Brazil has been hit badly by Covid-19.

New features published soon

To make the app suitable for Brazil was not that tough a thing as Etsimo’s cloud-based system has been built for global markets from the beginning. The whole process took only six weeks. 

To serve a new market, Etsimo has to make sure all common diseases are supported and have the correct prevalence, and translate the content to the languages of the target market. Etsimo also has to verify that the solution complies to local regulations. 

To make the app suitable for Brazil was not tough – the process took only six weeks.

So for Brazil, Etsimo added data of eight typical diseases such as Dengue fever to the healthcare solution, and for Covid-19, the company used official advice of Brazil. Etsimo translated all information to Portuguese, and applied and was granted the national medical device certification, ANVISA.

“It is important to take the country into consideration to avoid diagnostic errors. Now the app in Brazil contains altogether 755 diseases and 102 disease groups,” explains Grandell.

“We have top-notch data and medical, AI and machine learning expertise in Finland. Finnish researchers publish an equal amount of AI related research papers compared to MIT,” highlights Thomas Grandell, CEO of Etsimo.

Powered with AI and machine learning

So where has Etsimo gotten the data as the platform is powered with AI and machine learning?

“First, to teach our platform to make the right diagnoses we used the same data than the Finnish Medical Society Duodecim uses in its ‘Find the Diagnosis’ tool designed for doctors. It contains the symptoms of over 3,000 diagnoses. We have also used anonymized international data to develop the platform further,” says Grandell.

He highlights that the more there is data and real-life cases, the less there is uncertainty in the diagnoses of the platform.

Now in June 2020, the diagnosis engine will get new validated features as clinical evidence exists. The engine can classify the patient’s need for treatment according to urgency and recommend the right care path.

Startup Fast Facts

Name: Etsimo Healthcare

Product: AI and machine learning powered healthcare platform for predictive and preventive healthcare

Founded: 2016

Team size: 23

Target market: Healthcare providers, insurance companies, national health care systems

Saving time, money and lives

Since his graduation, Grandell has established companies and fostered his learning in tech. He thinks that the Finnish health ecosystem is a great place to develop solutions. Etsimo has partnered with Terveystalo, the largest private healthcare provider in the Nordics, since 2018. The company will start to use the diagnosis engine this June. In addition to Terveystalo, angel investors have invested in the company. 

“In general, we have top-notch data and medical, AI and machine learning expertise in Finland. Finnish researchers publish an equal amount of AI related research papers compared to MIT,” highlights Grandell.

The Etsimo team includes these experts. The international team used to work at various universities before spinning out to tackle societal problems.

“Some insurance agencies have estimated that 30 percent of all doctors’ appointments are unnecessary from a medical standpoint. To add up, Sitra, a Finnish future foundation, has come up to a conclusion that 50–70 percent of doctor’s appointments could be handled virtually,” says Grandell.

50–70 percent of doctor’s appointments could be handled virtually.

The healthcare platform not only boils down to efficient care and savings, but also to proper care at the right time. It can be difficult for a doctor to get a holistic view of a patient’s condition – and that is why the Etsimo platform can make a big difference. 

If Etsimo had been here six years ago, Grandell’s wife’s tumors would have been found faster and not by accident. Now all is well.

Text: Katja Alaja
Photos: Etsimo Healthcare

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn

Other case stories

from Greater Helsinki

Two researchers in white coats walkingKeksi Agency via City of Helsinki

TILT Biotherapeutics, rising superstar of oncolytic immunotherapy

Mar 21, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2020/04/Keksi-Agency-via-City-of-Helsinki_communications.jpg 1653 2480 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-03-21 08:00:272023-03-29 15:04:22TILT Biotherapeutics, rising superstar of oncolytic immunotherapy
Lumoral device and batteryKoite Health

Brushing your teeth is not enough – Finnish innovation reduces gingivitis efficiently

Nov 23, 2022
https://healthcapitalhelsinki.fi/wp-content/uploads/2022/11/Lumoral-laite-ja-akku-copy-res72.jpg 883 1335 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2022-11-23 14:04:292022-11-24 10:15:13Brushing your teeth is not enough – Finnish innovation reduces gingivitis efficiently
Design model of a wrist device to curb alcohol cravingsJuliana Harkki

Skin-stroking device to help curb alcohol cravings developed in Finland

https://healthcapitalhelsinki.fi/wp-content/uploads/2022/11/hentoTouch_ranne_v2_w1000.jpg 736 1000 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2022-11-14 16:13:032022-11-14 16:13:25Skin-stroking device to help curb alcohol cravings developed in Finland
All news

Health Capital Helsinki

Helsinki Partners
Kasarmikatu 36
00130 HELSINKI
FINLAND

Privacy notice

Sign up to our newsletter

Subscribe

Follow us

  • twitter
  • linkedin
Health Capital Helsinki
Scroll to top

We use cookies to give you the best experience on our website.

Find out more and set your preferences settings.

Powered by  GDPR Cookie Compliance
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential website cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are necessary to deliver the website as intended, refusing them will have impact how our site functions. You can always block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will prompt you to accept or refuse cookies every time you revisit our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Third party cookies

This website uses Twitter's and LinkedIn's cookies to help us improve our content and reach.

Please enable essential website cookies first so that we can save your preferences!

Privacy notice

You can read about how we use your data on our Privacy notice page.

Privacy notice